Clinical features of lupus myositis versus idiopathic myositis: A review of 30 cases

British Journal of Rheumatology

Volumn 36, Issue 10, 1997, Pages 1067-1074

  Garton, M J ^a   Isenberg, D A ^a,b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b Arthur Stanley House   (United Kingdom)

Author keywords

Dermatomyositis; Myometry; Polymyositis; Systemic lupus erythematosus

Indexed keywords

CREATINE KINASE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CREATINE KINASE BLOOD LEVEL; DERMATOMYOSITIS; FEMALE; FOLLOW UP; HUMAN; LABORATORY TEST; MALE; MORTALITY; MUSCLE WEAKNESS; MYOSITIS; ONSET AGE; POLYMYOSITIS; PRIORITY JOURNAL; QUADRICEPS FEMORIS MUSCLE; RELAPSE; SEX DIFFERENCE; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0030681410     PISSN: 02637103     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/36.10.1067     Document Type: Article

References (44)

1. Estes D, Christian CL. The natural history of systemic lupus erythematosus by prospective analysis. Medicine (Baltimore) 1971;50:85-95.
2. Feinglass EJ, Arnett FC, Dorsch CA, Zizic TM, Stevens MB. Neuropsychiatric manifestations of systemic lupus erythematosus: diagnosis, clinical spectrum, and relationship to other features of the disease. Medicine (Baltimore) 1976;55:323-39.
3. Fessel WJ. Systemic lupus erythematosus in the community. Arch Intern Med 1974;134:1027-35.
4. Tsokos GC, Moutsopoulos HM, Steinberg AD. Muscle involvement in systemic lupus erythematosus. J Am Med Assoc 1981;246:766-8.
5. Foot RA, Kimbrough SM, Stevens JC. Lupus myositis. Muscle Nerve 1982;5:65-8.
6. Michet CJ Jr, McKenna CH, Elveback LR, Kaslow RA, Kurland LT. Epidemiology of systemic lupus erythematosus and other connective tissue diseases in Rochester, Minnesota, 1950 through 1979. Mayo Clin Proc 1985;60:105-13.
7. Rose AL, Walton JN. Polymyositis: a survey of 89 cases with particular reference to treatment and prognosis. Brain 1966;89:747-68.
8. DeVere R, Bradley WG. Polymyositis: its presentation, morbidity and mortality. Brain 1975;98:637-66.
9. Pearson CM, Bohan A. The spectrum of polymyositis and dermatomyositis. Med Clin North Am 1977;61: 439-57.
10. Love LA, Leff RL, Fraser DD et al. A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups. Medicine (Baltimore) 1991;70:360-74.
11. Joffe MM, Love LA, Leff RA et al. Drug therapy of the idiopathic inflammatory myopathies: predictors of response to prednisone, azathioprine, and methotrexate and a comparison of their efficacy. Am J Med 1993;94:379-87.
12. Koh ET, Seow A, Ong B, Ratnagopal P, Tjia H, Chng HH. Adult onset polymyositis/dermatomyositis: clinical and laboratory features and treatment response in 75 patients. Ann Rheum Dis 1993;52:857-61.
13. Bohan A, Peter JB. Polymyositis and dermatomyositis. N Engl J Med 1975;292:334-47;403-7.
14. Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
15. Steinbrocker O, Traeger CH, Batterman RC. Therapeutic criteria in rheumatoid arthritis. J Am Med Assoc 1949;140:659-62.
16. Edwards RHT, Young A, Hosking GP, Jones DA. Human skeletal muscle function: description of tests and normal values. Clin Sci Mol Med 1977;52:283-90.
17. Reichlin M, Arnett FC Jr. Multiplicity of antibodies in myositis sera. Arthritis Rheum 1984;27:1150-6.
18. Ehrenstein MR, Snaith ML, Isenberg DA. Idiopathic myositis: a rheumatological view. Ann Rheum Dis 1992;51:41-4.
19. Nishikai M, Reichlin M. Heterogeneity of precipitating antibodies in polymyositis and dermatomyositis: characterization of the Jo-1 antibody system. Arthritis Rheum 1980;23:881-8.
20. Arad-Dann H, Isenberg DA, Shoenfeld Y, Offen D, Sperling J, Sperling R. Autoantibodies against a specific nuclear RNP protein in sera of patients with autoimmune rheumatic diseases associated with myositis. J Immunol 1987;138:2463-8.
21. Gardner MJ, Altman DG. Statistics with confidence. London: British Medical Journal 1990:28-33.
22. Tucker LB, Menon S, Schaller JG, Isenberg DA. Adult- and childhood-onset systemic lupus erythematosus: a comparison of clinical features, serology, and outcome. Br J Rheumatol 1995;34:866-72.
23. Bohan A, Peter JB, Bowman RL, Pearson CM. A computer-assisted analysis of 153 patients with polymyositis and dermatomyositis. Medicine (Baltimore) 1977;56: 255-86.
24. Hochberg MC, Feldman D, Stevens MB. Adult onset polymyositis/dermatomyositis: an analysis of clinical and laboratory features and survival in 76 patients with a review of the literature. Semin Arthritis Rheum 1986;15:168-78.
25. McKendry RJR. Influence of age at onset on the duration of treatment in idiopathic adult polymyositis and dermatomyositis. Arch Intern Med 1987;147:1989-91.
26. Benbassat J, Gefel D, Larholt K, Sukenil S, Morgenstern V, Zlotnick A. Prognostic factors in polymyositis/dermatomyositis. A computer-assisted analysis of ninety-two cases. Arthritis Rheum 1985;28:249-55.
27. Lilley H, Dennett X, Byrne E. Biopsy proven polymyositis in Victoria 1982-1987: analysis of prognostic factors. J R Soc Med 1994;87:323-6.
28. Medsger TA Jr, Robinson H, Masi AT. Factors affecting survivorship in polymyositis: a life-table study of 124 patients. Arthritis Rheum 1971;14:249.
29. Chwalinska-Sadowska H, Madykowa H. Polymyositis-dermatomyositis: 25 years of follow-up of 50 patients -disease course, treatment, prognostic factors. Mater Med Pol 1990;22:213-8.
30. Tymms KE, Webb J. Dermatopolymyositis and other connective tissue diseases: a review of 105 cases. J Rheumatol 1985;12:1140-8.
31. Estruch R, Grau JM, Fernandez-Sola J, Casademont J, Monforte R, Urbano-Marquez A. Microvascular changes in skeletal muscle in idiopathic inflammatory myopathy. Hum Pathol 1992;23:888-95.
32. Engel AG, Hohlfeld R, Banker BQ. The polymyositis and dermatomyositis syndromes. In: Engel AG, Franzini-Armstrong C, eds. Myology: basic and clinical, Vol. II. New York: McGraw-Hill, 1994:1335-83.
33. Henrikkson KG, Sandstedt P. Polymyositis - treatment and prognosis. Acta Neurol Scand 1982;65:280-300.
34. Fafalak RG, Peterson MGE, Kagen LJ. Strength in polymyositis and dermatomyositis: best outcome in patients treated early. J Rheumatol 1994;21:643-8.
35. Plotz PH, Dalakas M, Leff RL, Love LA, Miller FW, Cronin ME. Current concepts in the idiopathic inflammatory myopathies: polymyositis, dermatomyositis, and related disorders. Ann Intern Med 1989;111: 143-57.
36. Oxenhandler R, Hart MN, Bickel J, Scearce D, Durham J, Irvin W. Pathologic features of muscle in systemic lupus erythematosus. Hum Pathol 1982;13: 745-57.
37. Isenberg DA, Snaith ML. Muscle disease in SLE: a study of its nature, frequency and course. J Rheumatol 1981;8:917-24.
38. Miller FW. Cause and treatment of myositis. Plotz P, moderator. Myositis: immunologic contributions to understanding cause, pathogenesis, and therapy. Ann Intern Med 1995;122:715-24.
39. Gran JT, Mykleburst G, Johansen S. Adult idiopathic polymyositis without elevation of creatine kinase. Case report and review of the literature. Scand J Rheumatol 1993;22:94-6.
40. Kagen LJ, Aram S. Creatine kinase activity inhibitor in sera from patients with muscle disease. Arthritis Rheum 1987;30:213-7.
41. Bunch TW, Worthington JW, Combs JJ, Ilstrup DM, Engel AG. Azathioprine with prednisone for polymyositis. Ann Intern Med 1980;92:365-9.
42. Winkelmann RK, Mulder DW, Lambert EH, Howard FM, Diessner GR. Course of dermatomyositis-polymyositis: comparison of untreated and cortisone patients. Mayo Clin Proc 1968;43:545-56.
43. Fudman EJ, Schnitzer TJ. Clinical and biochemical characteristics of autoantibody systems in polymyositis and dermatomyositis. Semin Arthritis Rheum 1986;15: 255-60.
44. Van Rossum MAJ, Hiemstra I, Prieur AM, Rijkers GT, Kuis W. Juvenile dermato/polymyositis: a retrospective analysis of 33 cases with special focus on initial CPK levels. Clin Exp Rheumatol 1994;12:339-42.